Skip to content
naulon

Not checkedNot checked for notices yet.

Rituximab reduces the hospitalization in patients with systemic lupus erythematosus

López Longo J, Muñoz-Jiménez A, Velloso-Feijoo M L and 4 more

Journal of Translational Medicine · 2010

doi:10.1186/1479-5876-8-s1-p70 (opens in a new tab)

We email you when a new notice or a question about this paper appears.

Abstract

Systemic Lupus Erythematosus (SLE) is a chronic inflammatory disease of unknown etiology. The evolution of the disease is unpredictable. Most patients follow a chronic course and have flare-ups or exacerbations, with a number of hospital admissions.

Abstract licence: CC BY-NC-ND

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.